|
NCT02067975
|
2014-09-01 |
Tryptophan MRI in People With Schizophrenia and Healthy Controls
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT02184832
|
2014-08-01 |
Dietary Intake of Tryptophan and Metformin Response
|
Phase 0
|
Not Yet Recruiting
|
|
NCT02018588
|
2013-12-01 |
Tryptophan Requirement of Healthy School Age Children
|
Phase 1
|
Recruiting
|
|
NCT02280720
|
2013-01-01 |
Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent
|
Phase 4
|
Completed
|
|
NCT02051569
|
2012-08-01 |
Serotonin and Everyday Social Interaction
|
Phase 0
|
Completed
|
|
NCT02051530
|
2012-04-01 |
Mood, Serotonin and Social Interaction
|
Phase 0
|
Completed
|
|
NCT01191216
|
2010-09-01 |
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
|
Phase 1
|
Completed
|
|
NCT01042535
|
2009-12-01 |
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
|
Phase 1/Phase 2
|
Active, Not Recruiting
|
|
NCT00865202
|
2008-12-01 |
A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium
|
Phase 3
|
Completed
|
|
NCT00739609
|
2008-08-01 |
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
|
Phase 1
|
Terminated
|
|
NCT00567931
|
2007-10-01 |
1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
|
Phase 1
|
Completed
|
|
NCT00202124
|
2001-04-01 |
Double Blind Study of Trp01 in Patients With Alzheimer's Disease
|
Phase 4
|
Completed
|
|
NCT00000324
|
1997-03-01 |
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
|
Phase 2
|
Completed
|